Amylyx Pharmaceuticals, Inc. (AMLX)
13.55
+0.54
(+4.15%)
USD |
NASDAQ |
Jun 09, 16:00
13.55
0.00 (0.00%)
After-Hours: 20:00
Amylyx Pharmaceuticals SG&A Expense (Quarterly) : 16.17M for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Alumis, Inc. | 18.61M |
| Merck & Co., Inc. | 2.70B |
| Ocular Therapeutix, Inc. | 36.58M |
| ANI Pharmaceuticals, Inc. | 73.66M |
| Corcept Therapeutics, Inc. | 145.36M |